Flexibility of PCNA-protein interface accommodates differential binding partners

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Pedley, Anthony M ^a   Lill, Markus A ^a   Davisson, V Jo ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLINE; AKT1 PROTEIN, HUMAN; HYBRID PROTEIN; LIGAND; PEPTIDE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE 3 KINASE; PROTEIN BINDING; PROTEIN KINASE B;

ANISOTROPY; ARTICLE; BINDING SITE; EXPRESSION VECTOR; FLUORESCENCE POLARIZATION IMMUNOASSAY; HYDROGEN BOND; MOLECULAR DYNAMICS; MOLECULAR RECOGNITION; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SOLID PHASE SYNTHESIS; STOICHIOMETRY; CHEMICAL STRUCTURE; CHEMISTRY; CONSENSUS SEQUENCE; FLUORESCENCE POLARIZATION; HUMAN; METABOLISM; PROTEIN MOTIF; X RAY CRYSTALLOGRAPHY;

AMINO ACID MOTIFS; BINDING SITES; CLASS IA PHOSPHATIDYLINOSITOL 3-KINASE; CONSENSUS SEQUENCE; CRYSTALLOGRAPHY, X-RAY; FLUORESCENCE POLARIZATION; HUMANS; LIGANDS; MODELS, MOLECULAR; MOLECULAR DYNAMICS SIMULATION; PEPTIDES; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN INTERACTION MAPPING; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINANT FUSION PROTEINS;

EID: 84904490612     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0102481     Document Type: Article

References (60)

1. Maga G, Hübscher U (2003) Proliferating cell nuclear antigen (PCNA): a dancer with many partners. J Cell Sci 116: 3051-3060. doi:10.1242/jcs.00653. (Pubitemid 37038954)
2. Moldovan G-L, Pfander B, Jentsch S (2007) PCNA, the Maestro of the Replication Fork. Cell 129: 665-679. doi:10.1016/j.cell.2007.05.003. (Pubitemid 46802385)
3. Stoimenov I, Helleday T (2009) PCNA on the crossroad of cancer. Biochem Soc Trans 37: 605. doi:10.1042/BST0370605.
4. Mailand N, Gibbs-Seymour I, Bekker-Jensen S (2013) Regulation of PCNA-protein interactions for genome stability. Nat Rev Mol Cell Biol 14: 269-282. doi:10.1038/nrm3562.
5. Jónsson ZO, Hindges R, Hübscher U (1998) Regulation of DNA replication and repair proteins through interaction with the front side of proliferating cell nuclear antigen. EMBO J 17: 2412-2425. doi:10.1093/emboj/17. 8.2412.
6. Naryzhny SN (2008) Proliferating cell nuclear antigen: a proteomics view. Cell Mol Life Sci CMLS 65: 3789-3808. doi:10.1007/s00018-008-8305-x.
7. Zheleva DI, Zhelev NZ, Fischer PM, Duff SV, Warbrick E, et al. (2000) A quantitative study of the in vitro binding of the C-terminal domain of p21 to PCNA: affinity, stoichiometry, and thermodynamics. Biochemistry 39: 7388-7397. (Pubitemid 30422055)
8. Guo Z, Chavez V, Singh P, Finger LD, Hang H, et al. (2008) Comprehensive mapping of the C-terminus of flap endonuclease-1 reveals distinct interaction sites for five proteins that represent different DNA replication and repair pathways. J Mol Biol 377: 679-690. doi:10.1016/j.jmb.2007.10.074.
9. Warbrick E, Lane DP, Glover DM, Cox LS (1997) Homologous regions of Fen1 and p21Cip1 compete for binding to the same site on PCNA: a potential mechanism to co-ordinate DNA replication and repair. Oncogene 14: 2313-2321. doi:10.1038/sj.onc.1201072. (Pubitemid 27260723)
10. Bruning JB, Shamoo Y (2004) Structural and Thermodynamic Analysis of Human PCNA with Peptides Derived from DNA Polymerase-δ p66 Subunit and Flap Endonuclease-1. Structure 12: 2209-2219. doi:10.1016/j.str.2004.09.018. (Pubitemid 39593198)
11. Bubeck D, Reijns MAM, Graham SC, Astell KR, Jones EY, et al. (2011) PCNA directs type 2 RNase H activity on DNA replication and repair substrates. Nucleic Acids Res 39: 3652-3666. doi:10.1093/nar/gkq980.
12. Gulbis JM, Kelman Z, Hurwitz J, O'Donnell M, Kuriyan J (1996) Structure of the C-Terminal Region of p21WAF1/CIP1 Complexed with Human PCNA. Cell 87: 297-306. doi:10.1016/S0092-8674(00)81347-1. (Pubitemid 26359007)
13. Kontopidis G, Wu S-Y, Zheleva DI, Taylor P, McInnes C, et al. (2005) Structural and Biochemical Studies of Human Proliferating Cell Nuclear Antigen Complexes Provide a Rationale for Cyclin Association and Inhibitor Design. Proc Natl Acad Sci USA 102: 1871-1876. doi:10.1073/pnas.0406540102. (Pubitemid 40261979)
14. Boehr DD, Nussinov R, Wright PE (2009) The role of dynamic conformational ensembles in biomolecular recognition. Nat Chem Biol 5: 789-796. doi:10.1038/nchembio.232.
15. Brath U, Akke M (2009) Differential Responses of the Backbone and Side-Chain Conformational Dynamics in FKBP12 upon Binding the Transition-State Analog FK506: Implications for Transition-State Stabilization and Target Protein Recognition. J Mol Biol 387: 233-244. doi:10.1016/j.jmb.2009.01.047.
16. Fenwick RB, Prasannan S, Campbell LJ, Nietlispach D, Evetts KA, et al. (2009) Solution Structure and Dynamics of the Small GTPase RalB in Its Active Conformation: Significance for Effector Protein Binding. Biochemistry 48: 2192-2206. doi:10.1021/bi802129d.
17. Lu Z-L, Coetsee M, White CD, Millar RP (2007) Structural Determinants for Ligand-Receptor Conformational Selection in a Peptide G Protein-coupled Receptor. J Biol Chem 282: 17921-17929. doi:10.1074/jbc.M610413200. (Pubitemid 47100331)
18. Shima F, Yoshikawa Y, Ye M, Araki M, Matsumoto S, et al. (2013) In silico discovery of small-molecule Ras inhibitors that display antitumor activity by blocking the Ras-effector interaction. Proc Natl Acad Sci 110: 8182-8187. doi:10.1073/pnas.1217730110.
19. Pommier Y, Marchand C (2012) Interfacial inhibitors: targeting macromolecular complexes. Nat Rev Drug Discov 11: 25-36. doi:10.1038/nrd3404.
20. Wells JA, McClendon CL (2007) Reaching for high-hanging fruit in drug discovery at protein-protein interfaces. Nature 450: 1001-1009. doi:10.1038/nature06526. (Pubitemid 350273630)
21. Sakurai S, Kitano K, Yamaguchi H, Hamada K, Okada K, et al. (2005) Structural basis for recruitment of human flap endonuclease 1 to PCNA. EMBO J 24: 683-693. doi:10.1038/sj.emboj.7600519. (Pubitemid 40396099)
22. De Biasio A, Campos-Olivas R, Sánchez R, López-Alonso JP, Pantoja-Uceda D, et al. (2012) Proliferating Cell Nuclear Antigen (PCNA) Interactions in Solution Studied by NMR. PLOS ONE 7: e48390. doi:10.1371/journal.pone.0048390.
23. Schrodinger, LLC (n.d.) The PyMOL Molecular Graphics System. Schrodinger, LLC.
24. Zhang J-H, Chung TDY, Oldenburg KR (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4: 67-73. doi:10.1177/108705719900400206. (Pubitemid 29278954)
25. Nikolovska-Coleska Z, Wang R, Fang X, Pan H, Tomita Y, et al. (2004) Development and optimization of a binding assay for the XIAP BIR3 domain using fluorescence polarization. Anal Biochem 332: 261-273. doi:10.1016/j.ab.2004.05. 055. (Pubitemid 39485734)
26. Roehrl MHA, Wang JY, Wagner G (2004) A General Framework for Development and Data Analysis of Competitive High-Throughput Screens for Small-Molecule Inhibitors of Protein2Protein Interactions by Fluorescence Polarization. Biochemistry 43: 16056-16066. doi:10.1021/bi048233g. (Pubitemid 40041019)
27. Bowers KJ, Chow E, Xu H, Dror RO, Eastwood MP, et al. (2006) Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters. Proceedings of the ACM/IEEE SC 2006 Conference. pp. 43-43. doi:10.1109/SC.2006.54.
28. Humphrey W, Dalke A, Schulten K (1996) VMD: visual molecular dynamics. J Mol Graph 14: 33-38, 27-28.
29. Grant BJ, Rodrigues APC, ElSawy KM, McCammon JA, Caves LSD (2006) Bio3d: an R package for the comparative analysis of protein structures. Bioinformatics 22: 2695-2696. doi:10.1093/bioinformatics/btl461. (Pubitemid 44642612)
30. Case DA, Darden TA, Cheatham III TE, Simmerling CL, Wang J (2012) AMBER 12. University of California, San Francisco.
31. Meireles LMC, Dömling AS, Camacho CJ (2010) ANCHOR: a web server and database for analysis of protein-protein interaction binding pockets for drug discovery. Nucleic Acids Res 38: W407-W411. doi:10.1093/nar/gkq502.
32. Punchihewa C, Inoue A, Hishiki A, Fujikawa Y, Connelly M, et al. (2012) Identification of Small Molecule Proliferating Cell Nuclear Antigen (PCNA) Inhibitor That Disrupts Interactions with PIP-box Proteins and Inhibits DNA Replication. J Biol Chem 287: 14289-14300. doi:10.1074/jbc.M112.353201.
33. Cheng Y, Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108.
34. He X, Wei C, Song T, Yuan J, Zhang Y, et al. (2009) Proliferating cell nuclear antigen destabilizes c-Abl tyrosine kinase and regulates cell apoptosis in response to DNA damage. Apoptosis Int J Program Cell Death 14: 268-275. doi:10.1007/s10495-009-0313-2.
35. Hlinkova V, Xing G, Bauer J, Shin YJ, Dionne I, et al. (2008) Structures of monomeric, dimeric and trimeric PCNA: PCNA-ring assembly and opening. Acta Crystallogr D 64: 941-949. doi:10.1107/S0907444908021665.
36. Zhang P, Zhang S-J, Zhang Z, Woessner JF, Lee MYWT (1995) Expression and Physicochemical Characterization of Human Proliferating Cell Nuclear Antigen. Biochemistry 34: 10703-10712. doi:10.1021/bi00034a002.
37. Yao N, Turner J, Kelman Z, Stukenberg PT, Dean F, et al. (1996) Clamp loading, unloading and intrinsic stability of the PCNA, beta and gp45 sliding clamps of human, E. coli and T4 replicases. Genes Cells Devoted Mol Cell Mech 1: 101-113. (Pubitemid 126673110)
38. Prinz H (2010) Hill coefficients, dose-response curves and allosteric mechanisms. J Chem Biol 3: 37-44. doi:10.1007/s12154-009-0029-3.
39. Marqués M, Kumar A, Poveda AM, Zuluaga S, Hernández C, et al. (2009) Specific function of phosphoinositide 3-kinase beta in the control of DNA replication. Proc Natl Acad Sci 106: 7525-7530. doi:10.1073/pnas. 0812000106.
40. Xia L, Zheng L, Lee H-W, Bates SE, Federico L, et al. (2005) Human 3-Methyladenine-DNA Glycosylase: Effect of Sequence Context on Excision, Association with PCNA, and Stimulation by AP Endonuclease. J Mol Biol 346: 1259-1274. doi:10.1016/j.jmb.2005.01.014. (Pubitemid 40248827)
41. Rajamani D, Thiel S, Vajda S, Camacho CJ (2004) Anchor residues in protein-protein interactions. Proc Natl Acad Sci U S A 101: 11287-11292. doi:10.1073/pnas.0401942101. (Pubitemid 39038339)
42. Actis M, Inoue A, Evison B, Perry S, Punchihewa C, et al. (2013) Small molecule inhibitors of PCNA/PIP-box interaction suppress translesion DNA synthesis. Bioorg Med Chem 21: 1972-1977. doi:10.1016/j.bmc.2013.01.022.
43. Stites WE (1997) Protein2Protein Interactions: Interface Structure, Binding Thermodynamics, and Mutational Analysis. Chem Rev 97: 1233-1250. doi:10.1021/cr960387h.
44. Robertson AD (2002) Intramolecular interactions at protein surfaces and their impact on protein function. Trends Biochem Sci 27: 521-526. doi:10.1016/S0968-0004(02)02184-9.
45. Reichmann D, Rahat O, Cohen M, Neuvirth H, Schreiber G (2007) The molecular architecture of protein-protein binding sites. Curr Opin Struct Biol 17: 67-76. doi:10.1016/j.sbi.2007.01.004. (Pubitemid 46240815)
46. Xu H, Zhang P, Liu L, Lee MYWT (2001) A Novel PCNA-Binding Motif Identified by the Panning of a Random Peptide Display Library. Biochemistry 40: 4512-4520. doi:10.1021/bi010103+. (Pubitemid 32319597)
47. Gilljam KM, Feyzi E, Aas PA, Sousa MML, Müller R, et al. (2009) Identification of a Novel, Widespread, and Functionally Important PCNA-Binding Motif. J Cell Biol 186: 645-654. doi:10.1083/jcb.200903138.
48. Lea WA, Simeonov A (2011) Fluorescence Polarization Assays in Small Molecule Screening. Expert Opin Drug Discov 6: 17-32. doi:10.1517/17460441.2011. 537322.
49. Böhm H-J, Klebe G (1996) What Can We Learn from Molecular Recognition in Protein-Ligand Complexes for the Design of New Drugs? Angew Chem Int Ed Engl 35: 2588-2614. doi:10.1002/anie.199625881. (Pubitemid 27025001)
50. Doruker P, Atilgan AR, Bahar I (2000) Dynamics of proteins predicted by molecular dynamics simulations and analytical approaches: application to alpha-amylase inhibitor. Proteins 40: 512-524. (Pubitemid 30624460)
51. Cozzini P, Kellogg GE, Spyrakis F, Abraham DJ, Costantino G, et al. (2008) Target Flexibility: An Emerging Consideration in Drug Discovery and Design. J Med Chem 51: 6237-6255. doi:10.1021/jm800562d.
52. Chen U, Chen S, Saha P, Dutta A (1996) p21Cip1/Waf1 disrupts the recruitment of human Fen1 by proliferating-cell nuclear antigen into the DNA replication complex. Proc Natl Acad Sci 93: 11597-11602.
53. Bozza WP, Yang K, Wang J, Zhuang Z (2012) Developing peptide-based multivalent antagonists of proliferating cell nuclear antigen and a fluorescence-based PCNA binding assay. Anal Biochem 427: 69-78. doi:10.1016/j.ab.2012.04.018.
54. Kumar A, Fernandez-Capetillo O, Carrera AC (2010) Nuclear phosphoinositide 3-kinase β controls double-strand break DNA repair. Proc Natl Acad Sci USA 107: 7491-7496. doi:10.1073/pnas.0914242107.
55. Bahadur RP, Chakrabarti P, Rodier F, Janin J (2004) A Dissection of Specific and Non-specific Protein-Protein Interfaces. J Mol Biol 336: 943-955. doi:10.1016/j.jmb.2003.12.073. (Pubitemid 38201541)
56. Fridman Y, Palgi N, Dovrat D, Ben-Aroya S, Hieter P, et al. (2010) Subtle Alterations in PCNA-Partner Interactions Severely Impair DNA Replication and Repair. PLOS Biol 8: e1000507. doi:10.1371/journal.pbio.1000507.
57. Fridman Y, Gur E, Fleishman SJ, Aharoni A (2012) Computational protein design suggests that human PCNA-partner interactions are not optimized for affinity. Proteins Struct Funct Bioinforma 81: 341-348. doi:10.1002/prot.24190.
58. Pfander B, Moldovan G-L, Sacher M, Hoege C, Jentsch S (2005) SUMO-modified PCNA recruits Srs2 to prevent recombination during S phase. Nature 436: 428-433. doi:10.1038/nature03665. (Pubitemid 41059056)
59. Inoue A, Kikuchi S, Hishiki A, Shao Y, Heath R, et al. (2014) A Small Molecule Inhibitor of Monoubiquitinated Proliferating Cell Nuclear Antigen (PCNA) inhibits Repair of Interstrand DNA Crosslink, enhances DNA Double-strand Break, and sensitizes Cancer Cells to Cisplatin. J Biol Chem: jbc.M113.520429. doi:10.1074/jbc.M113.520429.
60. Talavera D, Robertson DL, Lovell SC (2011) Characterization of Protein-Protein Interaction Interfaces from a Single Species. PLOS ONE 6: e21053. doi:10.1371/journal.pone.0021053.